4/5/2022 | CV | Correction: Innoviva greenshoe ups 2.125% six-year convertibles to $261 million
|
4/1/2022 | CV | Market Commentary: Convertibles secondary begins new quarter slowly; Pinduoduo eyed; Block; Innoviva active
|
3/22/2022 | CV | Market Commentary: ADR names gain as buyers return to the space; Snap convertibles top par; Innoviva active
|
3/22/2022 | CV | Market Commentary: Morning Commentary: Innoviva convertibles active; Okta down outright in early trading
|
3/21/2022 | CV | Innoviva greenshoe ups 2.125% six-year convertibles to $270 million
|
3/4/2022 | CV | Market Commentary: Lumentum convertible notes price, volatile on aftermarket debut; Innoviva sinks further
|
3/3/2022 | CV | Market Commentary: Lumentum convertibles eyed, outstanding issues contract; Innoviva volatile on debut
|
3/3/2022 | CV | Market Commentary: Morning Commentary: Lumentum convertible notes eyed; Innoviva volatile on debut
|
3/3/2022 | CV | New Issue: Innoviva prices upsized $225 million six-year convertibles to yield 2.125%, up 35%
|
3/2/2022 | CV | Market Commentary: Innoviva convertibles eyed; Lucid losses mount; Peabody gains continue; Snap active
|
3/2/2022 | CV | Market Commentary: Morning Commentary: Innoviva convertibles on tap; secondary quiet with equities volatile
|
3/2/2022 | CV | Innoviva talks $200 million six-year convertible notes to yield 2.125%-2.625%, up 30%-35%
|
2/15/2022 | CV | Market Commentary: Virgin Galactic skyrockets outright, contracts on swap; Sea active; Innoviva gains
|
2/15/2022 | CV | Market Commentary: Morning Commentary: Innoviva convertible notes in focus early on quiet morning
|
8/23/2018 | BKCV | S&P ups Innoviva secured debt
|
8/23/2017 | CV | Market Commentary: Prospect Capital slips ahead of earnings; II-VI deal on deck; Innoviva’s recent 2.5% notes firm
|
8/23/2017 | CV | Market Commentary: Morning Commentary: Prospect Capital slips ahead of earnings; Innoviva’s recent 2.5% notes firm
|
8/7/2017 | CV | Innoviva greenshoe lifts 2.5% convertibles due 2025 to $192.5 million
|
8/2/2017 | CV | Market Commentary: Innoviva new issue prices, trades actively; Illumina paper firms; Tesla up as results eyed
|
8/2/2017 | CV | Market Commentary: Morning Commentary: Innoviva prices, dominates early trading; Illumina paper firms post-earnings
|
8/2/2017 | CV | New Issue: Innoviva sells $175 million 2.5% eight-year convertible notes, up 30%
|
8/1/2017 | CV | New Issue: Innoviva prices $175 million 2.5% convertibles due 2025, up 30%
|
8/1/2017 | CV | Market Commentary: Innoviva’s ‘old’ convertibles active ahead of new issue pricing; Intercept remains weak
|
8/1/2017 | BKCV | S&P assigns Innoviva loan BB, convertibles B+, B-
|
8/1/2017 | CV | Market Commentary: Morning Commentary: Innoviva plans new eight-year convertible bonds; ‘old’ bonds decline
|
8/1/2017 | CV | Innoviva’s $175 million convertibles due 2025 talked at 2.25%-2.75%, up 27.5%-32.5%
|
7/31/2017 | CV | Innoviva commences $175 million offering of eight-year convertibles
|